4.4 Article

The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics

期刊

CEPHALALGIA
卷 31, 期 10, 页码 1116-1130

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102411410610

关键词

Migraine; disability; resource utilization; HRQoL; web-based survey

资金

  1. Allergan, Inc., Irvine, CA
  2. Allergan
  3. Pfizer
  4. GlaxoSmithKline (GSK)
  5. Medtronic
  6. MSD
  7. Neuralieve
  8. Johnson Johnson
  9. Advanced Bionics
  10. Minster
  11. Merck
  12. Novartis
  13. OMP
  14. ProEthics/KOWA

向作者/读者索取更多资源

Objective: To describe a survey methodology to evaluate headache characteristics and burden and to present baseline characteristics for the international cohort of survey participants. Methods: A targeted, web-based methodology was used to recruit and survey subjects with migraine in 10 countries. Based on reported symptoms, subjects meeting ICHD-2 criteria for migraine were included; eligible subjects were classified as chronic (>= 15 headache days per month) or episodic (< 15 headache days per month). Outcomes included sociodemographic and clinical characteristics, resource utilization, disability, health-related quality of life, anxiety, depression and productivity. Results: Of 23,312 survey respondents, 11,897 were eligible and 9715 (81.7%) completed the survey; subjects were 81.5% female; 5.7% (n = 555) had chronic migraine. Conclusions: This is the first large international cohort of persons with chronic and episodic migraine studied using a web-based approach, a methodology well suited to the study of the burden of migraines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据